Trillium Asset Management’s Core Laboratories CLB Stock Holding History

Trillium Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-52,199	Closed	-$1.97M	–	237
2019 Q4	$1.97M	Sell	52,199 -13,067	-20%	-$587K	0.09%	162
2019 Q3	$3.04M	Sell	65,266 -490	-0.7%	-$22.8K	0.14%	137
2019 Q2	$3.44M	Buy	65,756 +1,117	+2%	+$65.5K	0.17%	135
2019 Q1	$4.46M	Buy	64,639 +3,979	+7%	+$267K	0.23%	118
2018 Q4	$3.62M	Sell	60,660 -1,276	-2%	-$110K	0.21%	125
2018 Q3	$7.17M	Buy	61,936 +14,233	+30%	+$1.61M	0.36%	95
2018 Q2	$6.02M	Buy	47,703 +6,432	+16%	+$783K	0.32%	102
2018 Q1	$4.47M	Buy	41,271 +23,180	+128%	+$2.57M	0.25%	115
2017 Q4	$1.98M	Buy	18,091 +7,460	+70%	+$745K	0.11%	152
2017 Q3	$1.05M	Buy	10,631 +185	+2%	+$17.9K	0.06%	172
2017 Q2	$1.06M	Buy	+10,446	New	+$1.13M	0.06%	175

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Trillium Asset Management's CLB Position: Q1 2020 in Review

Trillium Asset Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 52,199 shares — an estimated $1.97M sold.

Trillium Asset Management first reported a position in CLB in Q2 2017 and held it in 11 quarters. The position peaked at $7.17M in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Trillium Asset Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Trillium Asset Management sold 52,199 Core Laboratories shares in Q1 2020, an estimated $1.97M.
Trillium Asset Management first reported a position in Core Laboratories in Q2 2017 and held it in 11 quarters.
Trillium Asset Management's Core Laboratories position peaked at $7.17M in Q3 2018.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Trillium Asset Management's 13F filing for Q1 2020, filed 7 May 2020.